TNRC6A
Trinucleotide repeat-containing gene 6A protein
Also known as: CAGH26, GW182, KIAA1460, TNR6A_HUMAN, TNRC6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NDV7
- Gene
- TNRC6A
- Ensembl
- ENSG00000090905
- Chromosome
- 16
- Canonical length
- 1962 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles
OverviewNCBI Gene
This gene encodes a member of the trinucleotide repeat containing 6 protein family. The protein functions in post-transcriptional gene silencing through the RNA interference (RNAi) and microRNA pathways. The protein associates with messenger RNAs and Argonaute proteins in cytoplasmic bodies known as GW-bodies or P-bodies. Inhibiting expression of this gene delocalizes other GW-body proteins and impairs RNAi and microRNA-induced gene silencing. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1962 residues, UniProt reviewed canonical sequence.
>Q8NDV7|TNRC6A
1 MRELEAKATK DVERNLSRDL VQEEEQLMEE KKKKKDDKKK KEAAQKKATE QKIKVPEQIK
61 PSVSQPQPAN SNNGTSTATS TNNNAKRATA NNQQPQQQQQ QQQPQQQQPQ QQPQPQPQQQ
121 QPQQQPQALP RYPREVPPRF RHQEHKQLLK RGQHFPVIAA NLGSAVKVLN SQSESSALTN
181 QQPQNNGEVQ NSKNQSDINH STSGSHYENS QRGPVSSTSD SSTNCKNAVV SDLSEKEAWP
241 SAPGSDPELA SECMDADSAS SSESERNITI MASGNTGGEK DGLRNSTGLG SQNKFVVGSS
301 SNNVGHGSST GPWGFSHGAI ISTCQVSVDA PESKSESSNN RMNAWGTVSS SSNGGLNPST
361 LNSASNHGAW PVLENNGLAL KGPVGSGSSG INIQCSTIGQ MPNNQSINSK VSGGSTHGTW
421 GSLQETCESE VSGTQKVSFS GQPQNITTEM TGPNNTTNFM TSSLPNSGSV QNNELPSSNT
481 GAWRVSTMNH PQMQAPSGMN GTSLSHLSNG ESKSGGSYGT TWGAYGSNYS GDKCSGPNGQ
541 ANGDTVNATL MQPGVNGPMG TNFQVNTNKG GGVWESGAAN SQSTSWGSGN GANSGGSRRG
601 WGTPAQNTGT NLPSVEWNKL PSNQHSNDSA NGNGKTFTNG WKSTEEEDQG SATSQTNEQS
661 SVWAKTGGTV ESDGSTESTG RLEEKGTGES QSRDRRKIDQ HTLLQSIVNR TDLDPRVLSN
721 SGWGQTPIKQ NTAWDTETSP RGERKTDNGT EAWGSSATQT FNSGACIDKT SPNGNDTSSV
781 SGWGDPKPAL RWGDSKGSNC QGGWEDDSAA TGMVKSNQWG NCKEEKAAWN DSQKNKQGWG
841 DGQKSSQGWS VSASDNWGET SRNNHWGEAN KKSSSGGSDS DRSVSGWNEL GKTSSFTWGN
901 NINPNNSSGW DESSKPTPSQ GWGDPPKSNQ SLGWGDSSKP VSSPDWNKQQ DIVGSWGIPP
961 ATGKPPGTGW LGGPIPAPAK EEEPTGWEEP SPESIRRKME IDDGTSAWGD PSKYNYKNVN
1021 MWNKNVPNGN SRSDQQAQVH QLLTPASAIS NKEASSGSGW GEPWGEPSTP ATTVDNGTSA
1081 WGKPIDSGPS WGEPIAAASS TSTWGSSSVG PQALSKSGPK SMQDGWCGDD MPLPGNRPTG
1141 WEEEEDVEIG MWNSNSSQEL NSSLNWPPYT KKMSSKGLSG KKRRRERGMM KGGNKQEEAW
1201 INPFVKQFSN ISFSRDSPEE NVQSNKMDLS GGMLQDKRME IDKHSLNIGD YNRTVGKGPG
1261 SRPQISKESS MERNPYFDKD GIVADESQNM QFMSSQSMKL PPSNSALPNQ ALGSIAGLGM
1321 QNLNSVRQNG NPSMFGVGNT AAQPRGMQQP PAQPLSSSQP NLRAQVPPPL LSPQVPVSLL
1381 KYAPNNGGLN PLFGPQQVAM LNQLSQLNQL SQISQLQRLL AQQQRAQSQR SVPSGNRPQQ
1441 DQQGRPLSVQ QQMMQQSRQL DPNLLVKQQT PPSQQQPLHQ PAMKSFLDNV MPHTTPELQK
1501 GPSPINAFSN FPIGLNSNLN VNMDMNSIKE PQSRLRKWTT VDSISVNTSL DQNSSKHGAI
1561 SSGFRLEESP FVPYDFMNSS TSPASPPGSI GDGWPRAKSP NGSSSVNWPP EFRPGEPWKG
1621 YPNIDPETDP YVTPGSVINN LSINTVREVD HLRDRNSGSS SSLNTTLPST SAWSSIRASN
1681 YNVPLSSTAQ STSARNSDSK LTWSPGSVTN TSLAHELWKV PLPPKNITAP SRPPPGLTGQ
1741 KPPLSTWDNS PLRIGGGWGN SDARYTPGSS WGESSSGRIT NWLVLKNLTP QIDGSTLRTL
1801 CMQHGPLITF HLNLPHGNAL VRYSSKEEVV KAQKSLHMCV LGNTTILAEF ASEEEISRFF
1861 AQSQSLTPSP GWQSLGSSQS RLGSLDCSHS FSSRTDLNHW NGAGLSGTNC GDLHGTSLWG
1921 TPHYSTSLWG PPSSSDPRGI SSPSPINAFL SVDHLGGGGE SMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNRC6A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 21 nTPM
- blood vessel: 21 nTPM
- pituitary gland: 21 nTPM
- adrenal gland: 19 nTPM
- ovary: 19 nTPM
- cervix: 18 nTPM
Single-cell type
- somatotrophs: 2,198 nCPM
- thyrotrophs: 1,772 nCPM
- choroid plexus epithelial cells: 1,264 nCPM
- retinal pigment epithelial cells: 1,245 nCPM
- astrocytes: 1,093 nCPM
- lactotrophs: 998 nCPM
Immune cell
- memory B-cell: 1.1 nTPM
- naive B-cell: 1 nTPM
- plasmacytoid DC: 1 nTPM
- naive CD4 T-cell: 0.7 nTPM
- NK-cell: 0.6 nTPM
- basophil: 0.5 nTPM
Brain region
- cerebellum: 40 nTPM
- white matter: 33 nTPM
- hypothalamus: 33 nTPM
- cerebral cortex: 32 nTPM
- choroid plexus: 31 nTPM
- pons: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNRC6A.
Disease | AllUniProt
Conditions TNRC6A is implicated in, by any mechanism.
- Epilepsy, familial adult myoclonic, 6 (FAME6) MIM:618074
Disease | ImmuneIEDB
Conditions an epitope on TNRC6A was assayed in.
- autoimmune peripheral neuropathy B cell
- Sjogren's syndrome B cell
- ovarian cancer T cell
ReferencesPubMed · IEDB
Publications for TNRC6A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.
2003 · J Mol Med (Berl) · RCR 1.2 · 60 citations - RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets.
2019 · BMC Bioinformatics · RCR 0.8 · 20 citations - Optimization of immunoprecipitation-western blot analysis in detecting GW182-associated components of GW/P bodies.
2009 · Nat Protoc · RCR 0.5 · 24 citations - The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis.
2005 · J Rheumatol · RCR 0.3 · 18 citations - An SNP in the trinucleotide repeat region of the TNRC6A gene maps to a major TNGW1 autoepitope in patients with autoantibodies to GW182.
2013 · Adv Exp Med Biol · RCR 0.1 · 3 citations
Reference: B cellIEDB
1 publication
- Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182.
2003 · J Mol Med (Berl) · RCR 1.2 · 60 citations
Reference: T cellIEDB
1 publication
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.
2018 · Sci Transl Med · RCR 11.5 · 363 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to starvation
- endoderm development
- miRNA-mediated gene silencing by inhibition of translation
- miRNA-mediated post-transcriptional gene silencing
- P-body assembly
- positive regulation of nuclear-transcribed mRNA poly(A) tail shortening
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNRC6A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNRC6A as an antibody target. Whether an autoantibody or antibody against TNRC6A could matter depends on whether native TNRC6A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNRC6A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNRC6A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...